Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2013; 19(45): 8357-8365
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8357
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8357
Table 7 Results of the multivariate analysis of the magnetic resonance imaging findings for diagnosing hepatocellular carcinoma
| MRI findings | All lesions (n = 105) | Lesions excluding cysts and hemangiomas (n = 89) | ||||
| OR | 95%CI | P value | OR | 95%CI | P value | |
| Hyperintensity on T2-weighted images | 1.1 | 0.3-4.3 | 0.86 | 12.6 | 1.8-87.8 | 0.01 |
| Arterial enhancement | 1.8 | 0.4-7.0 | 0.42 | 3.5 | 0.5-22.8 | 0.18 |
| Arterial enhancement and washout on venous or equilibrium phase images | 102.0 | 10.3-1012.4 | < 0.001 | 16.9 | 1.3-221.1 | 0.03 |
| Hypointensity on 20-min hepatobiliary phase images | 1.8 | 0.4-8.6 | 0.48 | 6.7 | 1.1-41.9 | 0.04 |
- Citation: Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jatchavala J. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol 2013; 19(45): 8357-8365
- URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8357.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i45.8357